GWAS in NMDAR Encephalitis

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Autoimmune Encephalitis
Interventions
GENETIC

GWAS

"This is a non-interventional study involving biological samples (DNA). Samples are already stored in biobank repositories and collected as part of good clinical practice in the diagnostic process of patients with suspected autoimmune encephalitis, meaning that the standard diagnostic and therapeutic approaches will not be altered in the selected study population. Patients have already gave explicit written consent for biological specimens sampling and storage at the Centre de Ressources Biologiques des Hospices Civils de Lyon (CRB-HCL)/NeuroBioTec (including tissue, cells or biological fluids) and genetic analysis for research purposes (e.g. involving genes related to the disease for which the patient was followed). Additionally, patients will be informed about the present study."

Trial Locations (1)

Unknown

RECRUITING

Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER